Coronary Revascularization in Patients With Dialysis in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-01

Study Completion Date

2023-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

China patients in end stage renal disease receiving maintenance dialysis have a high risk of cardiovascular disease (CVD), with a prevalence of 45.5% approximately, and coronary artery disease (CAD) has been identified as the most common one. It remains unclear that what their treatment status is and whether this group of patients can benefit from revascularization in China. The investigators plan to recruit around 30 hospitals from 7 regions as study centers, which represent different levels of economic development in Mainland China. The detailed information includes demographics, medical history, coronary angiogram, in-hospital treatment and procedures, short-term and long-term outcomes. The aim of the study is to provide the real world knowledge about current status of coronary revascularization and prognosis in patients with CAD and dialysis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry

NCT05841082

Coronary Artery Disease End Stage Renal Disease Dialysis

UNKNOWN

Chinese Medicine on Deferring Dialysis Initiation

NCT02194946

End-Stage Renal Disease

UNKNOWN PHASE1/PHASE2

Prevention and Management of Cardiovascular and Cerebrovascular Complications in Maintenance Hemodialysis (MHD) Patients

NCT07335471

Uremia; Chronic Cardiovascular Diseases (CVD) Cerebrovascular Disorders +3 more

COMPLETED NA

Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease

NCT02021019

End-stage Renal Disease Hypertension

COMPLETED NA

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula

NCT06199609

End Stage Renal Disease Arteriovenous Fistula

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Dialysis Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Revascularization group

This group includes patients with dialysis who have received revascularization by percutaneous coronary intervention or coronary artery bypass grafting for coronary artery disease.

Revascularization

Intervention Type OTHER

Percutaneous coronary intervention and/or coronary bypass grafting for coronary artery disease

Medical treatment group

This group includes patients who have received medical therapy for coronary artery disease, not percutaneous coronary intervention or coronary artery bypass grafting.

Medical therapy

Intervention Type OTHER

Optimal medical therapy for coronary artery disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Revascularization

Percutaneous coronary intervention and/or coronary bypass grafting for coronary artery disease

Intervention Type OTHER

Medical therapy

Optimal medical therapy for coronary artery disease

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Catheterization or coronary bypass grafting

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 or above and 85 or below.
* Receives peritoneal dialysis or hemodialysis more than 1-time weekly and for more than 3 months.
* Diagnosed with coronary artery disease, including STEMI, NST-ACD, stable coronary artery disease.

Exclusion Criteria

* Pregnancy or lactation.
* Can't be cooperative because of a mental illness or other reasons.
* Malignant tumor or severe hepatic disease.
* Life expectancy is less than 1 year.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No